GLPwatch
Trials (2081)
Page 5 of 35.
- Side-to-Side Duodeno-ileostomy Versus Semaglutide in Adults With Obesity and Type 2 Diabetes
- Response to Semaglutide in Non-diabetic Obese Patients With Varying Degrees of Insulin Resistance
- Study of Semaglutide, and Cilofexor/Firsocostat, Alone and in Combination, in Adults With Cirrhosis Due to Nonalcoholic Steatohepatitis (NASH)
- Effect of LY3437943 Versus Placebo in Participants Who Have Obesity or Are Overweight
- A Study of Eloralintide (LY3841136) and Eloralintide With Tirzepatide in Participants With Overweight or Obesity
- A Study of Once-Daily NNC0090-2746 in Participants With Type 2 Diabetes Inadequately Controlled With Metformin
- The Effect of Glycemic Control and of GLP-1 Receptor Agonism on Islet GLP-1 in People With Type 1 and Type 2 Diabetes
- A Research Study to See How Well CagriSema Helps People With Type 2 Diabetes and Excess Body Weight Lose Weight
- Dulaglutide in Diabetic Patients, Relationship Between Arterial Stiffness, Endothelial Function, Clinical and Laboratory Variables
- Semaglutide for Smoking Cessation in Patients With Diabetes
- Saxenda® in Obese or Overweight Patients With Stable Bipolar Disorder (Investigator Initiated)
- A Study of the Effect of LY2189265 on Two Blood Pressure Drugs
- A Clinical Study of NLY01 in Patient's With Early Parkinson's Disease
- Impact of a One-Week Discontinuation of Semaglutide on Gastric Retention and Endoscopic Mucosal Visibility Scores
- Estimating the Impact of Obesity Medications on Clinical and Economic Outcomes
- Pharmacological Treatment - An Overview of Its Role in Managing Childhood Obesity
- Spartina® (Tirzepatide) Effectiveness and Safety Evaluation
- Effect of GLP-1 on Angiogenesis
- Effect of Empagliflozin and Dulaglutide on MAFLD in Patients With T2D
- Effect of Chronic Exenatide Therapy on Beta Cell Function and Insulin Sensitivity in T2DM
- A Long-term Trial to Compare the Effects of Liraglutide and Sulphonylurea (Glimepiride) Both in Combination With Metformin on Clinical, Endothelial and Image Markers of Cardiovascular Risk in Patients With Type 2 Diabetes
- GLP Analogs for Diabetes in Wolfram Syndrome Patients
- Open Label, 4 Week Study of ITCA 650 in Adults With Type 2 Diabetes
- Tirzepatide Combined With Cognitive-Behavioural Therapy (CBT) for Adults With Alcohol Use Disorder (AUD) and Overweight/Obesity (OOB)
- A Study of the Effect of Tirzepatide on How the Body Handles Birth Control Pills in Healthy Female Participants
- A Drug-Drug Interaction (DDI) Study of Orforglipron With Carbamazepine in Healthy Participants
- Endoscopic Ultrasound Guided Gastric Botulinum Toxin Injections Versus Glucagon Like Peptide 1 Receptor Agonist in Weight Loss
- GLP-1Ra Impact on Metabolic Outcomes in Stage 2 T1DM While Receiving Teplizumab
- Glucagon-like Peptide 1 Receptor Agonist in Acute Large Vessel Occlusion Stroke Treated by Reperfusion Therapies
- New Imaging Procedure for the Localisation of Insulinoma
- Evaluating Exenatide for the Treatment of Postprandial Hyperinsulinemic Hypoglycemia
- Efficacy and Safety of Semaglutide Versus Dulaglutide as add-on to Metformin in Subjects With Type 2 Diabetes.
- Efficacy and Safety of Empagliflozin or Semaglutide in Overweight/Obese Patients With Type 1 Diabetes
- Safety Study of Weekly Semaglutide in Chilean Participants With Type 2 Diabetes
- Liraglutide 3 mg for Knee Osteoarthritis
- A Study Designed to Determine the Safety and Pharmacological Response ofMKC253 Inhalation Powder in Adults With Type 2 Diabetes Mellitus
- Exenatide Study of Cardiovascular Event Lowering Trial (EXSCEL): A Trial To Evaluate Cardiovascular Outcomes After Treatment With Exenatide Once Weekly In Patients With Type 2 Diabetes Mellitus
- GLP-1 Plus Lifestyle for Overall Wellness: Find Your Way Forward
- Evaluation of the Efficacy and Safety of GLP-1 Receptor Agonist Therapy In Steroid-Induced Diabetes
- Effect of Liraglutide in Obese Women With Polycystic Ovary Syndrome
- Effects of Tirzepatide and Insulin Glargine on Glucolipid Metabolism and Brain Function in Patients With Type 2 Diabetes
- Efficacy and Safety of Orforglipron in Participants With Peripheral Artery Disease
- Comparison of Type 2 Diabetes Pharmacotherapy Regimens
- Use of a GLP-1R Agonist to Treat Opioid Use Disorder
- A Study of LY3841136 in Japanese Participants With Obesity or Overweight
- A Study of Tirzepatide (LY3298176) Once Weekly in Adolescent Participants Who Have Obesity or Overweight With Weight-Related Comorbidities
- A Research Study Looking at Long-term Blood Sugar Control in People With Type 2 Diabetes Being Treated With Xultophy® in a Real-world Setting in Italy
- Loxenatide Plus LNG-IUS in Endometrial Atypical Hyperplasia
- Research Study Looking at How Well Semaglutide Works in People Living With Obesity and Prediabetes
- Effect of Liraglutide in Combination With Sulfonylurea (SU) on Blood Glucose Control in Subjects With Type 2 Diabetes
- Effect of GLP-1 Receptor Agonism After Sleeve Gastrectomy
- Comparison of Exenatide Taken Before Lunch and Dinner With Before Breakfast and Dinner in Patients With Type 2 Diabetes
- 24-week Treatment With Lixisenatide in Type 2 Diabetes Insufficiently Controlled With Metformin and Insulin Glargine
- A Study of XW003 in Obese Participants With Obstructive Sleep Apnea But Not Receive Positive Airway Pressure Therapy
- Dulaglutide Versus Liraglutide in Obese Type 2 Diabetic Adolescents Using Metformin
- Pharmacokinetics of IBI362 in Subjects With and Without Renal Impairment
- A Study of Tirzepatide (LY3298176) in Participants With Obesity or Overweight for the Maintenance of Weight Loss
- A Research Study Comparing Wegovy to Other Weight Management Drugs in People Living With Obesity in America
- Brown Adipose Tissue as a Mechanistic Determinant of Semaglutide Treatment Response in Obesity (BAT-Sema Study)
- A Research Study to See How Well CagriSema Helps People in China With Excess Body Weight Lose Weight